Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Liquidia Corporation is a biotechnology business based in the US. Liquidia Corporation shares (LQDA) are listed on the NASDAQ and all prices are listed in US Dollars. Liquidia Corporation employs 51 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$3.01|
|52-week range||$2.34 - $6.48|
|50-day moving average||$2.65|
|200-day moving average||$2.82|
|Wall St. target price||$4.25|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.51|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-07-25)||N/A|
|1 month (2021-07-02)||9.06%|
|3 months (2021-05-05)||15.33%|
|6 months (2021-02-01)||N/A|
|1 year (2020-08-01)||N/A|
|2 years (2019-08-01)||N/A|
|3 years (2018-08-01)||N/A|
|5 years (2016-08-01)||N/A|
|Revenue TTM||$3.8 million|
|Gross profit TTM||$501,916|
|Return on assets TTM||-39.69%|
|Return on equity TTM||-127.9%|
|Market capitalisation||$125.8 million|
TTM: trailing 12 months
There are currently 779,363 Liquidia Corporation shares held short by investors – that's known as Liquidia Corporation's "short interest". This figure is 7.6% down from 843,424 last month.
There are a few different ways that this level of interest in shorting Liquidia Corporation shares can be evaluated.
Liquidia Corporation's "short interest ratio" (SIR) is the quantity of Liquidia Corporation shares currently shorted divided by the average quantity of Liquidia Corporation shares traded daily (recently around 493267.72151899). Liquidia Corporation's SIR currently stands at 1.58. In other words for every 100,000 Liquidia Corporation shares traded daily on the market, roughly 1580 shares are currently held short.
However Liquidia Corporation's short interest can also be evaluated against the total number of Liquidia Corporation shares, or, against the total number of tradable Liquidia Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Liquidia Corporation's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Liquidia Corporation shares in existence, roughly 20 shares are currently held short) or 0.0232% of the tradable shares (for every 100,000 tradable Liquidia Corporation shares, roughly 23 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Liquidia Corporation.
Find out more about how you can short Liquidia Corporation stock.
We're not expecting Liquidia Corporation to pay a dividend over the next 12 months.
Over the last 12 months, Liquidia Corporation's shares have ranged in value from as little as $2.34 up to $6.48. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Liquidia Corporation's is 0.0549. This would suggest that Liquidia Corporation's shares are less volatile than average (for this exchange).
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include LIQ861, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension; and LIQ865, a sustained-release formulation of bupivacaine for the treatment of local post-operative pain. The company also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. .
Everything we know about the Chobani IPO, plus information on how to buy in.
Everything we know about the Stronghold Digital Mining IPO, plus information on how to buy in.
Everything we know about the ROX Financial LP IPO, plus information on how to buy in.
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
Everything we know about the RenovoRx IPO, plus information on how to buy in.
Everything we know about the Draganfly IPO, plus information on how to buy in.
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
Everything we know about the Marpai IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.